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Abstract
Physiological cervical ectopy (CE) is commonly found in young women, during pregnancy or intake of oral contraceptives. 
The complicated (pathological) CE, particularly in conditions of vaginal microbiota disturbances and human papillomavirus (HPV) 
infection, requires intervention, including optimal treatment and effective relapse prevention approaches.
Aim. The aim of the research was to investigate the complicated CE clinical course and recurrence features on the basis of a 
retrospective analysis of archival medical records in order to optimize the tactics of the complicated CE management and the relapse 
prevention measures.
Materials and methods. In the observational cross-sectional retrospective study using the continuous sampling method were 
included 740 case reports of women, who underwent inpatient treatment of gynecological pathology in Lviv Municipal Clinical First 
Aid Hospital in 2006–2017. The inclusion criterion was the presence of firstly diagnosed or recurrent CE. Exclusion criteria: absence of 
CE colposcopic or morphological confirmation, presence of physiological CE (on conditions of cytological, bacterioscopical, bacterio-
logical and colposcopical abnormalities absence). Subsequently, three groups were formed: control group (n=150) – healthy women, who 
applied for a regular gynecological examination; group 1 (n=483) – women with firstly diagnosed CE; group 2 (n=257) – women with 
recurrent CE. Differences in mean values were considered significant with a probability level of at least 95 % (p<0.05).
Results. Patients with recurrent CE had more pregnancies (p<0.05) than the ones with firstly diagnosed CE and wom-
en of control group. The proportion of women with high parity in group 1 and group 2 was three times higher (p<0.05), than in 
group 3. The proportion of artificial abortions in patients of groups 1 and 2 was more than two times higher (p<0.05), than in women 
in the control group, group 2 patients had more miscarriages and missed miscarriages(p<0.05) in comparison to the control group. 
Menarche in patients with recurrent CE set in later in comparison to women of control group (p<0.05). In group 2, the proportion 
of women with polymenorrhea was three times higher (p<0.05), than in group 1 and control group respectively. The compromised 
gynecological history was more often (p<0.05) detected in group 1 and group 2, than in the control group. In patients with recurrent 
CE a third of gynecologic diseases in the history (32.30±2.92 %) and 23.60±1.93 % – in patients with the firstly diagnosed CE were 
pelvic inflammatory diseases, significantly (p<0.05) higher in comparison to the control group (3.33±1.47 %). Almost half of patients 
in group 1 (48.25±2.27 %) and group 2 (47.84±3.13 %) had the history of frequent infectious diseases, this indicator was significantly 
(p<0.05) higher in comparison to the control group (24.67±3.52 %). In patients with recurrent CE chronic diseases of different etiolo-
gy were diagnosed more often (p<0.05) - their share made up 8.24±1.72 %, while in patients with firstly diagnosed CE – 4.33±0.92 %, 
in women of the control group – 1.33±0.94 %.The firstly diagnosed CE was more frequent (in comparison to recurrent CE) (p<0.001) 
characterized by asymptomatic course, whereas about half of patients with recurrent CE (46.69±3.11 %) presented with different 
complaints. Cytological indicators of cervicitis were found more often in patients with firstly diagnosed and recurrent CE, than in 
women of control group, as well as vaginal candidosis (p<0.05). Patients with recurrent CE more often (p<0.05) underwent diather-
moconization (24.12±2.67 %) and cryodestruction of the cervix (8.17±1.71 %) in comparison to patients of group 1. The most often 
performed treatment method in patients of both groups was diathermoconization. Treatment methods aimed to restore the hormonal 
balance, to normalize the state of vaginal microbiota were rarely found in both group 1 and 2, drugs that affect the reparation and 
regeneration of the epithelium have not been used in any case.
Conclusions. Recurrent symptomatic complicated CE should be interpreted as a complex problem that requires a multi-polar 
approach aimed at hormonal homeostasis, local immunity, and vaginal biocenosis normalizing. These measures should precede 
invasive treatment and further create optimal conditions for regeneration of the cervix.
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1. Introduction
The presence of columnar epithelium on the vaginal portion of the cervix is known as 
cervical ectopy (CE), it is often diagnosed in young nulliparous women aged under 25 (in 52.2– 
90 % of cases) [1]. CE found in adolescents and women of a young age, during pregnancy, intake of 
estrogen-containing oral contraceptives [2] is considered to be physiological, does not require any 
treatment and is subject to dynamic monitoring.
Subsequently, in women with CE under the influence of reproductive hormones the physio-
logical process of metaplasia is activated and, as a result, the generative cells of the columnar ep-
ithelium are transformed into squamous epithelium by remodeling process, which involves active 
replication and cell differentiation [3].
The complicated (pathological) CE, particularly in conditions of vaginal microbiota distur-
bances and human papillomavirus (HPV) infection, requires intervention, especially taking into 
account the significant relapse rate, which has no tendency to decrease and reaches 40 % [4].
It has been established, that the presence of CE may increase the risk of sexually transmitted 
diseases (STDs) infection, in particular Chlamydia infection [5], Cytomegalovirus infection [6], 
HIV [7], and HPV [8]. 
Thus, the presence of active, long-term metaplastic changes creates favorable conditions for 
the HPV infection, its replication and persistence in the future [9, 10], which becomes especially 
relevant taking into account,that the HPV infection prevalence is the highest among women aged 
under 25–23.2 % [11]. In addition, in several cross-sectional studies, in particular among older 
women, a significant correlation between the presence of CE and the prevalence of HPV infection 
was found, in particular type 16 [12, 13] and even more frequent – type 18 [14], presence of which 
is known to be associated with the cervical adenocarcinoma. A number of recent studies have also 
found that vaginal biocenosis disturbances play an important role in the development of cervical 
squamous intraepithelial lesions [15, 16].
However, despite the fact that CE has been intensively studied in recent years, there is still no 
unanimous hypothesis explaining its etiopathogenesis, tactics of the complicated CE optimal treat-
ment (in particular, in conditions of vaginal microbiota disturbances and HPV infection) and effective 
technologies of relapse prevention, which substantiates the relevance of further study of this problem.
2. Aim of research
The aim of the study is to investigate the complicated CE clinical course and recurrence 
features on the basis of a retrospective analysis of archival medical records in order to optimize the 
tactics of the complicated CE management and relapse prevention measures.
3. Materials and Methods
In the observational cross-sectional retrospective study using the continuous sampling meth-
od were included 740 case reports of women, who underwent inpatient treatment of gynecological 
pathology in Lviv Municipal Clinical First Aid Hospital in 2006–2017. The inclusion criterion was 
the presence of firstly diagnosed or recurrent CE. 
Exclusion criteria: absence of CE colposcopic or morphological confirmation, presence of 
physiological CE(on conditions of cytological, bacterioscopical, bacteriological and colposcopical 
abnormalities absence).
Subsequently, three groups were formed:
– control group (n=150) – healthy women, who applied for a regular gynecological examination;
– group 1 (n=483) – women with firstly diagnosed CE;
– group 2 (n=257) – women with recurrent CE.
The following data was taken into account: age, obstetrical and gynecological history, ex-
tragenital pathology, complaints, laboratory diagnostic data (bacterioscopical, bacteriological, cy-
tological, molecular (PCR) data) and colposcopy results.
Statistical processing of the study results was conducted using the Student’s t-criteri-
on. Differences in mean values were considered significant with a probability level of at least 
95 % (p<0.05).
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4. Results
Firstly diagnosed CE was found in 65.27±1.75 % (n=483) of patients, recurrent CE – in 
34.73±1.75 % (n=257) of patients.
The average age of women in the control group was 26.55±0.64 years, in group 1 – 33.55± 
±0.58 years, in group 2 – 34.64±0.57 years. In all groups, the prevalence of women of early and 
active reproductive age (18–34 years) was found: in group 1 this cohort of patients amounted to 
60.31±3.05 %, in the group 2 – 59.42±2.23 %, whereas in the control group this indicator reached 
the value of 84.67±2.94 %.
Every sixth patient with the firstly diagnosed CE (15.32±1.64 %) and recurrent CE 
(15.56±2.26 %) at least once underwent inpatient treatment because of the threatened mis-
carriage or premature labor. In every fifth patient (21.74±1.88 % and 22.96±2.62 % respec-
tively), the complicated course of at least one pregnancy was diagnosed. Cervical rupture 
during the labor was diagnosed in 7.87±1.23 % of patients in group 1 and in 10.89±1.94 % of 
group 2 patients.
Menarche in patients with recurrent CE set in significantly (p<0.05) later (on average in 
13.59±0.05 years) in comparison to women of control group. 
The disorders of menstrual function were detected in more than half of women of all study 
groups (Table 1). 
Table 1
Peculiarities of obstetrical and gynecological history of patients with CE in comparison to control group
Indicator Group 1 (n=483)
Group 2 
(n=257)
Control group 
(n=150)
Parity: 1.80±0.06 2.03±0.09*** 1.16±0.09* **
– labors: 1.32±0.05 1.46±0.06 0.78±0.06* **
0, % 26.50±2.01 17.51±2.37*** 23.33±3.45
1, % 27.54±2.03 29.96±2.86 61.33±3.98* **
2 and more, % 45.96±2.27 52.53±3.11 15.33±2.94* **
– artificial abortions, % 15.73±1.66 14.79±2.21 6.67±2.04* **
– miscarriages, % 10.14±1.37 12.84±2.09 6.67±2.04**
– missed miscarriages, % 2.72±1.02 5.38±1.03 0.67±0.66**
Menarche, years: 13.47±0.06 13.59±0.05 13.39±0.88**
– early, % 0.83±0.41 1.95±0.86 1.33±0.94
– late, % 9.73±1.85 10.56±1.40 5.33±1.83**
Menopause, % 2.00±1.14 8.49±1.27*** 1.95±0.86**
Menstrual function disturbances, %: 64.39±2.18 59.53±3.06 58.00±4.03
– hypermenorrhea, % 3.54±1.05 10.46±2.47*** –
– oligomenorrhea, % 2.57±0.90 3.27±1.44 3.45±1.96
– dysmenorrhea (painful menstruation), % 61.41±2.76 57.52±4.00 60.92±5.23
– opsomenorrhea, % 3.22±1.00 5.23±1.80 5.75±2.50
– proyomenorrhea, % 3.45±1.96 9.80±2.40*** 2.25±0.84**
– irregular menstrual cycle, % 26.44±4.73 27.01±2.52 15.33±2.94**
Note: * – p<0.05 between group 1 and control group; ** –  p<0.05 between group 2 and control group; *** – p<0.05 between group 
1 and group 2
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The compromised gynecological history was detected in more than a third of patients with 
the firstly diagnosed CE (33.13±2.14 %) and recurrent CE (38.13±3.03 %).
Analyzing the structure of gynecological diseases history presented in Table 2, it can 
be noted that the proportion of adenomyosis was significantly (p<0.05) higher in patients with 
firstly diagnosed (9.32±1.32 %) and recurrent CE (8.56±1.75 %) in comparison to the control 
group (2.00±1.14 %). Patients of group 2 were more likely to have abnormal uterine bleeding 
(AUB) (31.52±2.90 %), Bartolin’s cyst (5.84±1.46 %) in history in comparison to group 1 (13.46± 
±1.55 % and 0.41±0.29 % respectively), while this pathology in women of the control group was 
not diagnosed. Also, proportion of ovarian cysts (14.40±2.19 %) and uterine fibroids (20.62± 
±2.52 %) was significantly (p<0.05) higher in patients with recurrent CE in comparison to group 
1 and control group.
In patients with recurrent CE a third of gynecologic diseases in the history (32.30±2.92 %) 
and 23.60±1.93 % – in patients with the firstly diagnosed CE were pelvic inflammatory diseases – 
chronic salpingitis, oophoritis and endometritis, significantly (p<0.05) higher in comparison to the 
control group(3.33±1.47 %).
It should be noted, that 12.22±1.49 % of patients in group 1 and 21.40±2.56 % of patients 
in group 2 had the history of laparoscopic or laparotomy surgery on internal reproductive organs, 
which is significantly higher (p<0.05) compared to the control group, where this indicator was 
6.00±1.94 %.
Table 2
The structure of gynecological diseases in the history of patients with CE and women of the control group
No. Disease Group 1 (n=483)
Group 2 
(n=257)
Control group 
(n=150)
1 Adenomatosis, % 1.04±0.46 0.39±0.39 –
2 Adenomyosis, % 9.32±1.32 8.56±1.75 2.00±1.14* **
3 AUB, % 13.46±1.55 31.52±2.90*** –
4 Bartolin’s cyst, % 0.41±0.29 5.84±1.46***
5 Cervical polyp, % 4.76±0.97 7.00±1.59 –
6 Chronic endometritis, % 3.93±0.88 5.84±1.46 –
7 Chronic salpingitis, oophorotis, % 19.67±1.81 26.46±2.75*** 3.33±1.47* **
8 CIN I, % 12.42±1.50 11.28±1.97 –
9 CIN IІ, % 1.86±0.62 5.84±1.46 –
10 CIN IІІ, % 0.62±0.36 0.78±0.55 –
11 Ectopic pregnancy, % 2.90±0.76 1.56±0.77 –
12 Endometrial hyperplasia, % 14.29±1.59 12.45±2.06 –
13 Endometriosis, % 2.90±0.76 1.56±0.77 –
14 Ovarian apoplexy, % 3.73±0.86 1.95±3.33 3.33±1.47
15 Ovarian cyst, % 9.11±1.31 14.40±2.19*** 6.00±1.94**
16 PCOS, % 2.28±0.68 0.78±0.55 1.33±0.94
17 Pelvic organ prolapse, % – 8.17±1.71 –
18 Primary sterility, % 1.24±0.50 1.17±0.67 4.00±1.60
19 Secondary sterility, % 0.62±0.36 – –
20 Uterine fibroids, % 11.39±1.45 20.62±2.52*** 3.33±1.47* **
Note: * – p<0.05 between group 1 and control group; ** – p<0.05 between group 2 and control group; *** – p<0.05 between group 
1 and group 2
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It was noted, that 48.25±2.27 % of patients in group 1 and 47.84±3.13 % – in group 2 had in 
the history frequent infectious diseases, this indicator was significantly (p<0.05) higher in compar-
ison to the control group (24.67±3.52 %). In patients with recurrent CE the share of chronic diseases 
of different etiology made up 8.24±1.72 %, while in patients with firstly diagnosed CE – 4.33± 
±0.92 %, in women of the control group – 1.33±0.94 %. The compromised allergic history was 
detected in 7.00±1.59 % of the patients in group 2, this indicator was significantly (p<0.05) higher, 
than the one in the control group (2.67±1.32 %). Among other diseases, the proportion of anemia 
should be noted, this indicator in group 1 (42.06±2.24 %) and group 2 (41.96±3.09 %) was almost 
two times higher (p<0.05) in comparison to the control group (25.33±3.55 %).
Firstly diagnosed CE was more frequently (in comparison to recurrent CE) (p<0.001) 
characterized by asymptomatic course, whereas about half of patients with recurrent CE (46.69± 
±3.11 %) presented with different complaints, the most common (p<0.05) – of the blood mixed 
discharge presence (compared with patients of group 1). Also, more often (p<0.001), than patients 
in group 1, this category of patients was disturbed by poscoital bleeding (5.45±1.42 %).
It is characteristic, that the interval from the moment of complicated symptomatic CE 
diagnosis to obtaining appropriate treatment in patients with recurrent CE was significantly 
(p<0.001) longer (compared to patients of group 1) and averaged 4.05±0.49 years. At the same 
time, it was noted, that in patients of group 2 carriage of high-risk HPV was diagnosed more 
often (p<0.05).
The colposcopy results in the two groups of patients were not significantly different, how-
ever, in patients of group 2, the presence of non-uniform iodine uptake zones was significantly 
(p<0.05) higher (Table 3).
Table 3
Features of the firstly diagnosed and recurrent CE clinical course
Indicator Group 1 (n=483) Group 2 (n=257)
Complaints, %: 28.57±2.06 46.69±3.11**
– lower abdominal pain, % 6.21±1.10 9.34±1.82
– blood mixed discharge, % 19.67±1.81 36.58±3.00**
– postcoital bleeding, % 2.07±0.65 5.45±1.42*
– foul smelling vaginal discharge, vaginal itching, % 7.45±1.20 8.95±1.78
Duration of CE presence, years 1.06±0.12 4.05±0.49**
High-risk HPV carriage, % 4.97±0.99 10.89±1.94*
CE diameter, cm 2.02±0.08 2.55±0.12**
Colposcopic findings:
– acetic-white epithelium, % 12.28±4.35 18.33±5.00
– atypical TZ, % – 1.67±1.65
– cervical hypertrophy, % 12.28±4.35 3.33±2.32
– dilatation of the superficial vessels, % 12.28±4.35 10.00±3.87
– excretory ducts of glands, % 7.02±3.38 1.67±1.65
– mosaic, % 10.53±4.06 13.33±4.39
– non-uniform iodine uptake zone, % 3.51±2.44 15.00±4.61*
– Nabothian cyst, % 14.04±4.60 6.67±3.22
– punctuation, % 8.77±3.75 11.67±4.14
– TZ type 1, % 14.04±4.60 18.33±5.00
Note: * – p<0.05 between group 1 and control group; ** – p<0.05 between group 2 and control group
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The highest percentage of cytological norm was found in women of the control group – 
60.00±4.00 % (Pap smear) and 93.33±2.04 % respectively (Bethesda, 2001), which is significantly 
(p<0.05) higher, than in patients of group 1 and 2. Identical trends were also observed in the case 
of type IIA and IIB (Pap smear) and ASC-US (Bethesda, 2001).
The level of leukocytes found during bacterioscopy was significantly (p<0.05) higher in 
patients of group 1 (35.04±1.73 %) and group 2 (37.75±1.38 %) in comparison to the control group 
(13.99±1.21 %) (Table 4).
Table 4
Features of cytology, bacterioscopy and bacteriology in patients with CE and women of control group
Indicator Group 1 (n=483) Group 2 (n=257) Control group (n=150)
Cytology:
– Pap smear
type І, % 19.05±1.79 16.34±2.31 60.00±4.00* **
type ІІА, % 47.41±2.27 48.64±3.12 33.33±3.85* **
type ІІB, % 20.08±1.82 23.35±2.64 6.67±2.04* **
type ІІІА, % 11.80±1.47 10.12±1.88 –
type ІІІB, % 1.66±0.58 1.56±0.77 –
– Bethesda (2001)
NILM, % 66.46±2.15 64.98±2.98 93.33±2.04* **
ASC-US, % 20.08±1.82 23.35±2.64 6.67±2.04* **
LSIL, % 11.80±1.47 10.12±1.88 –
HSIL, % 1.66±0.58 1.56±0.77 –
Bacterioscopy:
– flora
bacilli, % 67.70±2.13 66.15±2.95 71.33±3.69
cocci, % 8.70±1.28 8.56±1.75 4.67±1.72
mixed, % 23.60±1.93 25.29±2.71 24.00±3.49
– leucocytes 35.04±1.73 37.75±1.38 13.99±1.21* **
Bacteriology:
– C. albicans, % 19.07±2.45 26.29±2.00 13.33±2.78* **
– G. vaginalis, % 8.00±2.22 7.00±1.59 5.80±1.06
– Tr. vaginalis, % 2.33±0.94 3.31±0.81 0.67±0.66**
– pseudomycosis, % 2.72±1.02 4.55±0.95 2.67±1.32
Note: * – p<0.05 between group 1 and control group; ** – p<0.05 between group 2 and control group
Conservative treatment was taken by patients with firstly diagnosed CE significant-
ly (p<0.001) more rarely (26.29±2.00 % of cases) and mainly included local NSAIDs (28.57± 
±2.06 %) and wide spectrum antibiotic therapy (20.29±1.83 %). Only in 11.39±1.45 % of cases 
vaginal antiseptics were used, in 3.93±0.88 % of cases- treatment aimed to restore the hormonal 
balance, in 1.86±0.62 % of cases – drugs that normalize the state of vaginal microbiota. Drugs that 
affect the reparation and regeneration of the epithelium have not been prescribed in any case. A 
similar trend was observed in patients with recurrent CE.
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While analyzing the structure of surgical treatment methods, it was noted, that patients with 
recurrent CE significantly (p<0.05) more often underwent diathermoconization (24.12±2.67 %) and 
cryodestruction of the cervix (8.17±1.71 %) in comparison to patients of group 1. The treatment meth-
od most often performed in patients of both groups was particular diathermoconization (Fig. 1).
Fig. 1. The structure of CEsurgical treatment methods (* – p<0.05 between group 1 and group 2)
It should be noted, that 5.80±1.06 % of group 1 patients and 6.23±1.51 % of group 2 patients, 
who underwent either loop excision, or diathermoconization at the time of the intervention were 
nulliparous.
5. Discussion
In recent years the medical community attitude to the CE has shifted its vector: with the 
introduction of colposcopy and the implementation of the Bethesda system (2001) principles [17] in 
the routine medical practice, CE is now commonly interpreted as a physiological state, which does 
not require any intervention.
However, there is a problem unsolved concerning patients category, in which the presence 
of CE is associated with definite clinical symptoms, which create discomfort and may affect the 
quality of life, as well as the pathological CE, when the epithelization is complicated or impeded 
due to the presence of hormonal, local immunity, vaginal biocenosis disorders, HPV infection and 
chronic vaginal or cervical inflammatory processes.
We studied the clinical course and recurrence features of both firstly diagnosed and recur-
rent CE, which should be taken into account when choosing thecomplicated CEoptimal treatment 
tactics, also aiming to prevent its relapse in the future.
Analyzing the obstetrical and gynecological history (Table 1), it was found that patients 
with recurrent CE had significantly (p<0.05) more pregnancies, than the ones with firstly diag-
nosed CE and healthy women. A similar connection was noted in other studies [18]. The proportion 
of women with high parity (2 and more labors per vias naturalis) in group 1 and group 2 was three 
times higher (p<0.05), than in group 3, which can be explained by the probable relationship be-
tween obstetric trauma and CE in this contingent of patients [19].
The proportion of artificial abortions in the history of patients in groups 1 and 2 was 
more than two times higher (p<0.05), than in women of the control group. In addition, group 2 
patients had significantly more (p<0.05) miscarriages and missed miscarriages in comparison to 
the control group.
It was also found that hypermenorrhea was significantly (p<0.05) more commonly diag-
nosed in patients of group 2 in comparison to group 1, this disturbance was not found among 
women of control group. In group 2, the proportion of women with polymenorrhea was three times 
higher (p<0.05), than in group 1 and control group respectively.
Compromised gynecological history (especially concerning the pathology related with hor-
monal disturbances and chronic pelvic inflammatory diseases) was more typical for patients with 
CE: this indicator was significantly (p<0.05) higher in group 1 and group 2, than in the control group. 
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Almost half of patients in group 1 and group 2 had in the history frequent (more than 3 times 
a year) infectious diseases (ARI, influenza, pneumonia), this indicator was significantly (p<0.05) 
higher in comparison to the control group. In patients with recurrent CE chronic diseases of differ-
ent etiology (in particular, chronic bronchitis, tonsillitis, pyelonephritis) were diagnosed more often 
(p<0.05), than in group 1 and control group.
The size of the CE, measured during colposcopy, in patients of group 2, compared to pa-
tients of group 1, was significantly (p<0.001) greater. It was found, that in the presence of CE with 
a diameter greater than 3.5 mm, the risk of postcoital bleeding increases [20], which explains the 
higher prevalence of this symptom in patients with recurrent CE.
The frequent presence of cervicitis cytological indicators in patients with firstly diagnosed 
and recurrent CE correlates with the results of other studies: Singh et al. [21], studying the etiology 
of inflammatory cervical smears, found CE in a significant proportion of patients; moreover, the 
presence of CE can be associated with recurrent cervicitis [19].
This fact should be taken into account when choosing the treatment method for complicated 
CE, as it has been established that, in particular, cryodestruction of CE in patients with ≥3 episodes 
of cervicitis exacerbation during the past 6 months was 9 times less effective [19].
Vaginal candidiasis was diagnosed more often (p<0.05) in patients with firstly diagnosed 
and recurrent CE in comparison with control group (Table 4). A similar feature of vaginal micro-
biota was discovered by other researchers [22], who suggest that the dominance of C. albicans is a 
favorable factor for CE existence [23].
As our study showed, in practice, surgical treatment methods of complicated CE are still 
commonly used, unlike the treatment aimed at normalizing hormonal balance, vaginal microbiota, 
and promoting the processes of cervical epithelium regeneration. The shifting of the emphasis from 
the causes of CE and its long-term existence to the elimination of the consequences - the CE itself, 
is probably also one of the recurrence causes.
6. Conclusions
1. Complicated recurrent CE should not be treated as an isolated pathology, that can be 
eliminated radically and quickly using only local means (both drugs and surgery), but as a possible 
indicator of reproductive health in women and should not be neglected.
2. The risk factors of recurrent CE include: 2 or more labors per vias naturalis, abortions, 
artificial abortions, miscarriages and missed miscarriages in the history, late menarche, menstrual 
function disorders such as polymenorrhea, compromised gynecological history (the diseasespro-
voked by hormonal homeostasis disorders: adenomyosis, ovarian cysts, uterine fibroids, as well as 
chronic pelvic inflammatory diseases), the presence of extragenital pathology (frequent infectious 
diseases, chronic diseases, compromised alergological history, anemia).
3. Recurrent CE is characterized by symptomatic clinical course, it is more often combined 
with the HPV carriage, colpitis and cervicitis (often of mixed etiology), disturbances of vaginal 
microbiota, but at the same time, patients tend to postpone treatment for a long time.
4. Among the used first-line treatment methods of firstly diagnosed as well as recurrent CE, 
the lion’s share takes surgical treatment in combination with the common use of wide spectrum 
antibacterial therapy and non-steroidal anti-inflammatory drugs.
5. Thus, recurrent symptomatic complicated CE should be interpreted as a complex problem 
that requires a multi-polar approach aimed at hormonal homeostasis, local immunity, and vaginal 
biocenosis normalizing. These measures should precede invasive treatment and further create op-
timal conditions for the cervix regeneration.
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Abstract
Diffuse large B-cell lymphoma (DLBCL) is a potentially curable disease, but standard treatment is not effective enough for 
all patients. That is why so important to identify high risk patients who need more aggressive therapy at the time of diagnosis. Now-
adays prognosis for patients with DLBCL is based on International prognostic index (IPI). However, this index consists of only clin-
ical parameters and does not include the biological characteristics of the tumour. Immunohistochemistry (IHC) markers could also 
play a prognostic role. There are some publications regarding predictive and prognostic role of expression of Bcl-2, Bcl-6, MUM1, 
CD10 and CD30, but their results are controversial. The aim of our study was to analyze prognostic role of these markers, to compare 
survival of patients with positive and negative expression of these markers and to build a prognostic model which include biological 
parameters for identifying high risk patients. There were statistically significant differences in EFS between the group of patients 
with negative and positive expression of CD10 (51.5 % versus 72.5 %, р=0.01) and in OS between the group of patients with negative 
and positive expression of Bcl-6 (61.1 % versus 79.6 %, р=0.03). Six-factors nonlinear neural network prediction model (MLP_6) was 
built. The sensitivity of the model is 63.2 % (95 % CІ 49.3 % – 75.6 %), specificity – 85.2 % (95 % CІ 79.1 % – 90.1 %). Prognostic 
factors include negative IHC expression of Bcl-6, CD10, non-GCB molecular subtype (according to algorithm Hans), gender (male), 
advanced Ann-Arbor stages, >2 extranodal involvement. Our nonlinear neural network prediction model could improve prognostic 
role of IPI by adding of biological tumour characteristics (IHC expression of CD10, Bcl-6, molecular subtype by IHC algorithm).
Keywords: diffuse large B-cell lymphoma, prognosis, predictive model, biological characteristics.
DOI: 10.21303/2504-5679.2018.00564 © Arina Martynchyk, Vitaliy Gurianov, Iryna Kriachok
